Paul Hendrix, MD
Gastroenterology · Idaho Falls, IDNPI 1649249947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 52.8% of the total. Reporting peaked in 2024 at $448 and has fallen 78.8% since, to $95 in 2025. That places this record below the midpoint for gastroenterology clinicians in ID, where the typical reported total is $1,538.
Across 86 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$812
- Bristol Myers Squibb$224
- Phathom Pharmaceuticals, Inc.$103
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$81
- Boston Scientific$53
- Sanofi$50
- plus $216 from 8 others
Across 55 payments — averaging $6877.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$204K
- Regeneron$163K
- E.r. Squibb & Sons, L.L.C.$11K
What the payments were for
- Food & beverage$1,538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $812 |
| Bristol Myers Squibb | 12 | $224 |
| Phathom Pharmaceuticals, Inc. | 2 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Boston Scientific | 3 | $53 |
| Sanofi | 3 | $50 |
| Medtronic | 2 | $48 |
| Johnson & Johnson | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| Pfizer | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Orphalan Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Merck | 1 | $13 |
How this compares
$1,538 in reported general payments places this provider in the 50th percentile of 70 gastroenterology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PentasaMesalamine | 21 | $16,505 |
| Budesonide DrBudesonide | 30 | $12,908 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 154 | $9,949 |
| MovantikNaloxegol Oxalate | 17 | $9,474 |
| Omeprazole | 350 | $1,925 |
| Sucralfate | 20 | $1,789 |
| Colestipol Hcl | 19 | $968 |
| Dicyclomine Hcl | 23 | $605 |
| Pantoprazole Sodium | 50 | $593 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 23 | $334 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $181 |
| Metoclopramide Hcl | 19 | $130 |
| Azathioprine | 15 | $126 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Idaho Falls
- Todd WilliamsIdaho Falls$8K
- Larry EvansIdaho Falls$7K
- Ned WarnerIdaho Falls$7K
- Michael RichinsIdaho Falls$6K
- Clint BehrendIdaho Falls$4K
- Jacob WendlingIdaho Falls$421
- David JohnsonCoeur D Alene$190K
- Matthew SericatiBoise$111K
- Ashley EvansBoise$69K
- Bryan BrimhallBoise$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.